Zdrowie i gospodarka · 03/12/1999

FDA Releases Guidance on Impurities in Drug Substances for ANDA's

The Food and Drug Administration (FDA) has made available a new guidance document that outlines recommendations for including information on impurities in drug substances in abbreviated new drug applications (ANDA's) and supporting drug master files.